U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07696585) titled 'New Topical Treatment in Patchy Alopecia Areata' on June 28.
Brief Summary: Alopecia areata (AA) is a chronic immune disease characterized by non-scarring hair loss of the scalp or other hair-bearing areas Patients with AA frequently report high levels of dissatisfaction with commonly used treatment options due to ineffectiveness and adverse effects. Therefore, a substantial unmet need exists for safe and effective treatments for patients with AA. Metformin is a derivative of biguanide that is the most widely used as an oral antihyperglycemic agent for the control of diabetes mellitus. The main mechanism of action for metformin invo...